We are live on ! Find out more
PVLA

Palvella Therapeutics
PVLA

82 hedge funds and large institutions have $83.6M invested in Palvella Therapeutics in 2020 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 27 increasing their positions, 21 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 21

22% more capital invested

Capital invested by funds: $68.8M → $83.6M (+$14.9M)

0.05% less ownership

Funds ownership: 0.79% → 0.75% (-0.05%)

7% less funds holding

Funds holding: 88 → 82 (-6)

38% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 16

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $56K

Holders
82
Holders Change
-6
Holders Change %
-6.82%
% of All Funds
1.45%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
10
Increased
27
Reduced
21
Closed
16
Calls
–
Puts
$56K
Net Calls
-$56K
Net Calls Change
-$73K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$1.84M
2
SFM
Sphera Funds Management
Israel
+$1.43M
3
JP Morgan Chase
JP Morgan Chase
New York
+$449K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$397K
5
BlackRock
BlackRock
New York
+$176K

Top Sellers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
-$990K
2
Bank of America
Bank of America
North Carolina
-$609K
3
Russell Investments Group
Russell Investments Group
United Kingdom
-$479K
4
Cerity Partners
Cerity Partners
New York
-$468K
5
Renaissance Technologies
Renaissance Technologies
New York
-$311K
Name Holding Trade Value Shares
Change 		Change in
Stake
Dimensional Fund Advisors
26
Dimensional Fund Advisors
Texas
$468K +$9.15K +44 +2%
Wells Fargo
27
Wells Fargo
California
$464K -$26.6K -128 -5%
CHAM
28
Clear Harbor Asset Management
Connecticut
$418K -$90.1K -433 -17%
N
29
Nuveen
North Carolina
$414K +$4.58K +22 +1%
FDCDDQ
30
Federation des caisses Desjardins du Quebec
Quebec, Canada
$388K -$63.8K -307 -14%
SO
31
STRS Ohio
Ohio
$349K – – –
Los Angeles Capital Management
32
Los Angeles Capital Management
California
$323K -$208 -1 -0.1%
Charles Schwab
33
Charles Schwab
California
$320K +$22K +106 +7%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$314K -$19.6K -94 -6%
Deutsche Bank
35
Deutsche Bank
Germany
$264K +$5.41K +26 +2%
California Public Employees Retirement System
36
California Public Employees Retirement System
California
$251K – – –
AQR Capital Management
37
AQR Capital Management
Connecticut
$246K -$63.2K -304 -20%
Millennium Management
38
Millennium Management
New York
$235K +$43.7K +210 +22%
CS
39
Credit Suisse
Switzerland
$227K +$31.2K +150 +15%
6CM
40
683 Capital Management
New York
$225K – – –
Russell Investments Group
41
Russell Investments Group
United Kingdom
$210K -$479K -2,304 -69%
California State Teachers Retirement System (CalSTRS)
42
California State Teachers Retirement System (CalSTRS)
California
$199K +$9.57K +46 +5%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$157K +$10.2K +49 +7%
UBS Group
44
UBS Group
Switzerland
$148K +$31.2K +150 +26%
AllianceBernstein
45
AllianceBernstein
Tennessee
$145K – – –
Two Sigma Investments
46
Two Sigma Investments
New York
$137K +$114K +549 +398%
William Blair & Company
47
William Blair & Company
Illinois
$125K +$130K +625 New
PPA
48
Parametric Portfolio Associates
Washington
$114K +$49.7K +239 +73%
Bank of America
49
Bank of America
North Carolina
$111K -$609K -2,927 -84%
Barclays
50
Barclays
United Kingdom
$102K -$15.2K -73 -13%
1
2
3 4

PVLA Hedge Fund Activity: Q4 2020 in Review

82 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Palvella Therapeutics (PVLA) for Q4 2020, worth a combined $83.6M — up 22% from $68.8M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of PVLA and 10 opened new positions — a net loss of 6 holders — while 21 trimmed existing stakes and 27 added.

The largest buyer was Morgan Stanley, adding an estimated $1.84M. The largest seller was Woodline Partners, cutting an estimated $990K.

  • 82 institutional investors held Palvella Therapeutics (PVLA) as of Q4 2020, down from 88 in Q3 2020.
  • Funds reported $83.6M of Palvella Therapeutics stock for Q4 2020, up 22% quarter-over-quarter.
  • 10 funds opened new Palvella Therapeutics positions in Q4 2020 and 16 closed out, a net change of -6 holders.
  • The largest Palvella Therapeutics buyer in Q4 2020 was Morgan Stanley, an estimated $1.84M added.
  • The largest Palvella Therapeutics seller in Q4 2020 was Woodline Partners, an estimated $990K sold.

Based on aggregated 13F filings for Q4 2020.